{"id":"botox-epic","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or bruising"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Facial weakness or asymmetry"},{"rate":null,"effect":"Ptosis (eyelid drooping)"}]},"_chembl":{"chemblId":"CHEMBL1201574","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Botulinum toxin type A cleaves SNARE proteins required for acetylcholine vesicle release, leading to temporary paralysis of targeted muscles. Botox-Epic appears to be a formulation variant, potentially with modified onset or duration characteristics compared to standard botulinum toxin preparations. The mechanism remains neuromuscular blockade for cosmetic or therapeutic muscle relaxation.","oneSentence":"Botox-Epic is a botulinum toxin formulation that blocks acetylcholine release at the neuromuscular junction to reduce muscle contractions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:42:31.658Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cosmetic reduction of facial wrinkles and dynamic lines"},{"name":"Therapeutic muscle hyperactivity disorders (likely, based on phase 3 status)"}]},"trialDetails":[{"nctId":"NCT02767635","phase":"PHASE3","title":"Comparison Between Steroid and Different Sites of Botulinum Toxin Injection in the Treatment of Lateral Epicondylalgia","status":"UNKNOWN","sponsor":"National Cheng-Kung University Hospital","startDate":"2012-01","conditions":"Tennis Elbow","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["onabotulinumtoxinA"],"phase":"phase_3","status":"active","brandName":"Botox-Epic","genericName":"Botox-Epic","companyName":"National Cheng-Kung University Hospital","companyId":"national-cheng-kung-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Botox-Epic is a botulinum toxin formulation that blocks acetylcholine release at the neuromuscular junction to reduce muscle contractions. Used for Cosmetic reduction of facial wrinkles and dynamic lines, Therapeutic muscle hyperactivity disorders (likely, based on phase 3 status).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}